Hepatitis C Virus Infection Completed Phase 3 Trials for Asunaprevir (DB11586)

DBCOND0033268 (Hepatitis C Virus Infection)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02123654UNITY 3: A Japanese Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 in Subjects With Genotype 1 Chronic Hepatitis CTreatment
NCT01718145A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV SubjectsTreatment